BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20535484)

  • 1. Paediatric intussusception caused by acquired immunodeficiency syndrome-associated Kaposi sarcoma.
    Ramdial PK; Sing Y; Hadley GP; Chotey NA; Mahlakwane MS; Singh B
    Pediatr Surg Int; 2010 Aug; 26(8):783-7. PubMed ID: 20535484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intussusception as the initial manifestation of AIDS associated with primary Kaposi's sarcoma: a case report.
    Wang NC; Chang FY; Chou YY; Chiu CL; Lin CK; Ni YH; Liu YC
    J Formos Med Assoc; 2002 Aug; 101(8):585-7. PubMed ID: 12440091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of Kaposi sarcoma and non-Hodgkin lymphoma on mortality of people with AIDS in the highly active antiretroviral therapies era.
    Serraino D; De Paoli A; Zucchetto A; Pennazza S; Bruzzone S; Spina M; De Paoli P; Rezza G; Dal Maso L; Suligoi B
    Cancer Epidemiol; 2010 Jun; 34(3):257-61. PubMed ID: 20413362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma.
    Nasti G; Martellotta F; Berretta M; Mena M; Fasan M; Di Perri G; Talamini R; Pagano G; Montroni M; Cinelli R; Vaccher E; D'Arminio Monforte A; Tirelli U; ;
    Cancer; 2003 Dec; 98(11):2440-6. PubMed ID: 14635079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of Kaposi's sarcoma in patients with acquired immunodeficiency syndrome in São Paulo, Brazil.
    Yoshioka MC; Alchorne MM; Porro AM; Tomimori-Yamashita J
    Int J Dermatol; 2004 Sep; 43(9):643-7. PubMed ID: 15357742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS-associated Kaposi sarcoma: outcomes after initiation of antiretroviral therapy at a university-affiliated hospital in urban Zimbabwe.
    Nelson BC; Borok MZ; Mhlanga TO; Makadzange AT; Campbell TB
    Int J Infect Dis; 2013 Oct; 17(10):e902-6. PubMed ID: 23809198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous colesional acquired immunodeficiency syndrome associated Kaposi sarcoma and cryptococcosis.
    Ramdial PK; Sing Y; Subrayan S; Calonje E
    Am J Dermatopathol; 2010 Dec; 32(8):780-6. PubMed ID: 20802305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi sarcoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.
    Franceschi S; Maso LD; Rickenbach M; Polesel J; Hirschel B; Cavassini M; Bordoni A; Elzi L; Ess S; Jundt G; Mueller N; Clifford GM
    Br J Cancer; 2008 Sep; 99(5):800-4. PubMed ID: 18665172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological Features and Mortality in Patients With Kaposi Sarcoma and HIV: A Retrospective Analysis of a Thirty-Year Study From a Peruvian Oncologic Center.
    Cuellar LE; Meza K; Holguín AM; Velarde J; Portillo-Alvarez D; Castro V; Sulca-Huamani O; Intimayta-Escalante C; Gaby-Pérez R; Patel A
    JCO Glob Oncol; 2022 Jun; 8():e2100379. PubMed ID: 35728013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for Kaposi's sarcoma in human immunodeficiency virus patients after initiation of antiretroviral therapy: A nested case-control study in Kenya.
    Lupia R; Wabuyia PB; Otiato P; Fang CT; Tsai FJ
    J Microbiol Immunol Infect; 2017 Dec; 50(6):781-788. PubMed ID: 26712092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of highly active antiretroviral therapy on survival in patients with AIDS-associated pulmonary Kaposi's sarcoma treated with chemotherapy.
    Holkova B; Takeshita K; Cheng DM; Volm M; Wasserheit C; Demopoulos R; Chanan-Khan A
    J Clin Oncol; 2001 Sep; 19(18):3848-51. PubMed ID: 11559722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired immunodeficiency syndrome-related malignancies in the era of highly active antiretroviral therapy.
    Bernstein WB; Little RF; Wilson WH; Yarchoan R
    Int J Hematol; 2006 Jul; 84(1):3-11. PubMed ID: 16867895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.
    Nasti G; Talamini R; Antinori A; Martellotta F; Jacchetti G; Chiodo F; Ballardini G; Stoppini L; Di Perri G; Mena M; Tavio M; Vaccher E; D'Arminio Monforte A; Tirelli U;
    J Clin Oncol; 2003 Aug; 21(15):2876-82. PubMed ID: 12885804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of human herpesvirus 8 infection and interferon-gamma response in cutaneous lesions of Kaposi sarcoma differ among human immunodeficiency virus-infected and uninfected individuals.
    Guedes F; de Andrade HF; Fernandes ER; Tuon FF; Brasil RA; Pagliari C; Duarte MI
    Br J Dermatol; 2008 Sep; 159(4):839-46. PubMed ID: 18644020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing pattern of Kaposi sarcoma in patients with HIV, 1994-2003: the EuroSIDA Study.
    Mocroft A; Kirk O; Clumeck N; Gargalianos-Kakolyris P; Trocha H; Chentsova N; Antunes F; Stellbrink HJ; Phillips AN; Lundgren JD
    Cancer; 2004 Jun; 100(12):2644-54. PubMed ID: 15197808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of plasma human herpesvirus 8 DNA as a marker of clinical outcomes during antiretroviral therapy for AIDS-related Kaposi sarcoma in Zimbabwe.
    Borok M; Fiorillo S; Gudza I; Putnam B; Ndemera B; White IE; Gwanzura L; Schooley RT; Campbell TB
    Clin Infect Dis; 2010 Aug; 51(3):342-9. PubMed ID: 20572760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma.
    Portsmouth S; Stebbing J; Gill J; Mandalia S; Bower M; Nelson M; Bower M; Gazzard B
    AIDS; 2003 Jul; 17(11):F17-22. PubMed ID: 12853764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The presentation and survival of patients with non-cutaneous AIDS-associated Kaposi's sarcoma.
    Stebbing J; Mazhar D; Lewis R; Palmieri C; Hatzimichael E; Nelson M; Gazzard B; Bower M
    Ann Oncol; 2006 Mar; 17(3):503-6. PubMed ID: 16311274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS-Related Kaposi Sarcoma Associated with Steroid-Unresponsive Periorbital Lymphedema that Responded to Chemotherapy.
    Zeng Y; Prasad R; King RD; Joshi R; Lane J; Shriber S; Shweikeh F; Zhang Y
    Am J Case Rep; 2023 Mar; 24():e938801. PubMed ID: 36879523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of highly active antiretroviral therapy on AIDS-associated Kaposi's sarcoma.
    Dupin N; Rubin De Cervens V; Gorin I; Calvez V; Pessis E; Grandadam M; Rabian C; Viard JP; Huraux JM; Escande JP
    Br J Dermatol; 1999 May; 140(5):875-81. PubMed ID: 10354025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.